23andMe should have raised less capital
My takeaway from today’s news that the company is filing for bankruptcy
Making sense of healthcare deals, technology, policy, and the occasional industry curveball.
My takeaway from today’s news that the company is filing for bankruptcy
Guest author Halle Tecco’s breakdown of how the companies valued at more than $1b at the peak are faring — TLDR, the results surprised her!
What is keeping employers up at night going into 2025? A conversation with Chris Michalak
A few thoughts...
Between Function Health, Lifeforce and Superpower, this space is on fire
And what are the pros and cons?
I caught up with Conceivable Life Sciences’ Joshua Abram to understand the political landscape and its impact on reproductive health
Some digital health companies are getting more targeted with their approach